Literature DB >> 17542453

Viral hepatitis vaccination in an opioid treatment program: Hartford, Connecticut, 2002-2005.

Paul McLaughlin1.   

Abstract

Hartford Dispensary, a private, not-for-profit behavioral health care organization specializing in opioid treatment program services, serves more than 4,200 clients per day in seven licensed facilities. In May 2002, the Dispensary began offering free combined hepatitis A and B vaccine for all eligible clients in two Hartford clinics. Initial eligibility criteria required a client to be hepatitis C antibody positive, hepatitis B virus (HBV) surface antigen (HBsAg) negative, not pregnant, and not have a contraindication due to a medical condition. From May 2002 through April 2005, 5,419 doses of combined vaccine were given. Of the 2,072 clients who received a first dose, 92% (1,914) received the second dose and 69% (1,433) completed the series. Long treatment duration, frequent client visits, availability of medical staff, and counseling support contributed to high rates of combined vaccine series completion in the two programs. Opioid treatment programs appear to be good settings in which to provide hepatitis vaccination for high-risk adults.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17542453      PMCID: PMC1831815          DOI: 10.1177/00333549071220S209

Source DB:  PubMed          Journal:  Public Health Rep        ISSN: 0033-3549            Impact factor:   2.792


  4 in total

1.  Integrating hepatitis services into substance abuse treatment programs: new initiatives from SAMHSA.

Authors:  Thomas F Kresina; Kenneth Hoffman; Robert Lubran; H Westley Clark
Journal:  Public Health Rep       Date:  2007       Impact factor: 2.792

2.  Fulminant hepatitis associated with hepatitis A virus superinfection in patients with chronic hepatitis C.

Authors:  S Vento; T Garofano; C Renzini; F Cainelli; F Casali; G Ghironzi; T Ferraro; E Concia
Journal:  N Engl J Med       Date:  1998-01-29       Impact factor: 91.245

3.  Integrating viral hepatitis prevention services into an urban STD clinic: Denver, Colorado.

Authors:  Julie Subiadur; Jennie L Harris; Cornelis A Rietmeijer
Journal:  Public Health Rep       Date:  2007       Impact factor: 2.792

4.  Integrating viral hepatitis prevention into STD clinics in Illinois (excluding Chicago), 1999-2005.

Authors:  Richard Zimmerman; Carol Finley; Charlie Rabins; Karen McMahon
Journal:  Public Health Rep       Date:  2007       Impact factor: 2.792

  4 in total
  2 in total

1.  Integrating viral hepatitis prevention into public health programs serving people at high risk for infection: good public health.

Authors:  Joanna Buffington; T Stephen Jones
Journal:  Public Health Rep       Date:  2007       Impact factor: 2.792

Review 2.  Hepatitis infection in the treatment of opioid dependence and abuse.

Authors:  Thomas F Kresina; Diana Sylvestre; Leonard Seeff; Alain H Litwin; Kenneth Hoffman; Robert Lubran; H Westley Clark
Journal:  Subst Abuse       Date:  2008-04-28
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.